Protein seipin regulates fat development through cytoskeleton remodeling

February 12, 2014
Protein seipin regulates fat development through cytoskeleton remodeling
When insulin is present, the protein 14-3-3β (green) interacts with cofilin-1 (red) to reshape the cell’s internal structure and influence the development of fat cells. Credit: Oxford University Press

People with mutations in a gene called BSCL2 suffer from a rare medical condition known as lipodystrophy in which fat tissue is lost from where it is supposed to accumulate while being deposited at unusual sites around the body. However, the way in which these mutations lead to defects in the development and distribution of fat cells, or adipocytes, remained unclear.

Now, Weiping Han and co-workers from the A*STAR Singapore Bioimaging Consortium have dissected the molecular pathway by which seipin, the protein encoded by BSCL2, helps to remodel the cellular scaffolding in fat precursor cells—a process that is essential for proper fat formation.

To reveal the role of seipin in regulating the development of from , Han and his colleagues analyzed the protein players that interact with seipin using mass spectrometry techniques. Seipin is expressed in the endoplasmic reticulum, the organelle involved in trafficking molecules within the cell.

Han and his team discovered that seipin binds to a called 14-3-3β in the cytoplasm. In the presence of the hormone insulin, the 14-3-3β protein, a critical scaffolding molecule in signal transduction, subsequently recruits another protein called cofilin-1, which is otherwise found in the cell nucleus (see image). This second protein modulates actin microfilaments in the cytoskeleton that help to support the internal structure of the cell.

The researchers showed that initiation of this molecular cascade resulted in extensive remodeling of the during fat and maturation. Therefore, blocking the production of any of the four proteins in the pathway—seipin, 14-3-3β, cofilin-1 or actin—led to abnormal fat production in cell culture experiments. "Cytoskeleton remodeling is both necessary for, and a key regulator of, fat formation," explains Han.

Han suggests that the manipulation of any of the four proteins could form the basis of therapies for lipodystrophy. "The targeting of cytoskeleton remodeling may be a potential approach to promoting adipocyte development," he says. "This in turn will alleviate the overloading of lipids in non-adipose tissues and organs and the consequent insulin resistance—hallmarks of lipodystrophy."

Toward that end, Han and his colleagues have engineered a seipin-deficient mouse strain. The model mice develop a disease that looks similar to the lipodystrophy seen in humans. "We will test whether the manipulation of cytoskeleton remodeling can reverse the phenotype," Han explains, "and also whether this helps to alleviate the other associated metabolic phenotypes, such as insulin resistance."

Explore further: Reducing liver protein SIRT1 levels

More information: Yang, W., Thein, S., Wang, X., Bi, X., Ericksen, R. E. et al. BSCL2/seipin regulates adipogenesis through actin cytoskeleton remodelling. Human Molecular Genetics 23, 502–513 (2014). dx.doi.org/10.1093/hmg/ddt444

Related Stories

Reducing liver protein SIRT1 levels

January 22, 2014
A new study led by Boston University School of Medicine (BUSM) demonstrates that the abnormal metabolism linked to obesity could be regulated in part by the interaction of two metabolic regulators, called the NAD-dependent ...

Clues point to cause of a rare fat-distribution disease

March 20, 2013
Studying a protein that gives structure to the nucleus of cells, Johns Hopkins researchers stumbled upon mutations associated with familial partial lipodystrophy (FPLD), a rare disease that disrupts normal patterns of fat ...

New hormone for lowering blood sugar

April 3, 2012
New evidence points to a hormone that leaves muscles gobbling up sugar as if they can't get enough. That factor, which can be coaxed out of fat stem cells, could lead to a new treatment to lower blood sugar and improve metabolism, ...

Activity of cancer inducing genes can be controlled by the cell's skeleton

May 6, 2013
Cancer is a complex disease, in which cells undergo a series of alterations, including changes in their architecture; an increase in their ability to divide, to survive and to invade new tissues or metastasis. A category ...

Recommended for you

The 16 genetic markers that can cut a life story short

July 27, 2017
The answer to how long each of us will live is partly encoded in our genome. Researchers have identified 16 genetic markers associated with a decreased lifespan, including 14 new to science. This is the largest set of markers ...

A rogue gene is causing seizures in babies—here's how scientists wants to stop it

July 26, 2017
Two rare diseases caused by a malfunctioning gene that triggers seizures or involuntary movements in children as early as a few days old have left scientists searching for answers and better treatment options.

Scientists provide insight into genetic basis of neuropsychiatric disorders

July 21, 2017
A study by scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) is providing insight into the genetic basis of neuropsychiatric disorders. In this research, the first mouse model of a mutation ...

Scientists identify new way cells turn off genes

July 19, 2017
Cells have more than one trick up their sleeve for controlling certain genes that regulate fetal growth and development.

South Asian genomes could be boon for disease research, scientists say

July 18, 2017
The Indian subcontinent's massive population is nearing 1.5 billion according to recent accounts. But that population is far from monolithic; it's made up of nearly 5,000 well-defined sub-groups, making the region one of ...

Mutant yeast reveals details of the aberrant genomic machinery of children's high-grade gliomas

July 18, 2017
St. Jude Children's Research Hospital biologists have used engineered yeast cells to discover how a mutation that is frequently found in pediatric brain tumor high-grade glioma triggers a cascade of genomic malfunctions.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.